申请人:Hafslund Nycomed Pharma Aktiengesellschaft
公开号:US05627198A1
公开(公告)日:1997-05-06
The invention relates to heterocyclic amides of the formula ##STR1## in which the radicals A, Z, A.sub.1, R.sub.1, R.sub.2 and R.sub.3 are as defined in the description, to a process for the preparation of these amides and to their use as active substances for the curing and amelioration of disorders and diseases which can be treated by exerting influence on potassium channels.
该发明涉及具有以下结构的杂环酰胺:其中基A、Z、A.sub.1、R.sub.1、R.sub.2和R.sub.3如描述中所定义,以及制备这些酰胺的方法,以及它们作为治疗和改善可以通过对钾通道施加影响来治疗的疾病和紊乱的活性物质的用途。